Infusion Express Announces $22.5 Million Capital Raise, Rebrands as IVX Health
Ambulatory infusion center operator Infusion Express today announced completion of a $22.5 million funding round, which will enable the company to accelerate its nationwide expansion. Infusion Express also announced that it will rebrand as IVX Health.
McKesson Ventures and Health Velocity Capital co-led the funding round, joined by existing investor Nueterra Capital and new investor CrimsonNox Capital. The new round of funding will enable IVX Health to accelerate the growth of its infusion centers, not just in its existing markets but in new markets around the country as well.
“McKesson Ventures continues to support IVX Health’s vision to be the nation’s preferred destination for pharmaceutical care for patients with complex chronic conditions,” said McKesson Ventures Managing Director Dave Schulte. “We are excited to play a strategic role in IVX Health’s rapid growth as they pioneer a better care model that truly puts patients first.”
As IVX Health continues its expansion, all its new infusion centers will open under the IVX Health name and brand. Existing centers will continue to operate under the Infusion Express banner until Q4 2019, when the company plans to rebrand those as IVX Health centers, too.
IVX Health currently operates infusion centers in Kansas City, Philadelphia, Chicago, and San Francisco, and is planning to open new centers in Nashville, Tennessee; Harrisburg, Pennsylvania; and Columbus, Ohio in the coming months. The company will expand into additional markets in 2020.
IVX Health offers an alternative to hospital-based infusion and injection services. It allows patients to experience a superior level of service in a cost-effective, convenient site of care. In addition to conveniences like high-speed wi-fi, patients can enjoy private suites, large flat-screen TVs, and the convenience of scheduling appointments at any time, including evenings and weekends.
“Our commitment is to provide world-class service and clinical excellence to those receiving ongoing biologic infusion or injection therapy,” said IVX Health CEO Doug Ghertner. “We believe the IVX Health brand honors our strong heritage while better aligning with our mission to redefine the care experience for those with complex chronic conditions. The IVX Health name and brand ensures a stronger foundation for us moving forward as we seek to serve more and more patients over the coming years.”
Read the full press release here.